Feature Ciclofilin developing first drug for HCV/HIV-1 co-infection By Len Zehr Closely held Ciclofilin Pharmaceuticals is developing what, it hopes, will be the first clinically effective treatment for hepatitis C virus (HCV)/HIV-1 co-infection, with specific antiviral activity... June 24, 2014